Literature DB >> 25423127

Sepsis attenuates the anabolic response to skeletal muscle contraction.

Jennifer L Steiner1, Charles H Lang.   

Abstract

Electrically stimulated muscle contraction is a potential clinical therapy to treat sepsis-induced myopathy; however, whether sepsis alters contraction-induced anabolic signaling is unknown. Polymicrobial peritonitis was produced by cecal ligation and puncture (CLP) in male C57BL/6 mice and time-matched, pair-fed controls (CON). At ∼24 h post-CLP, the right hindlimb was electrically stimulated via the sciatic nerve to evoke maximal muscle contractions, and the gastrocnemius was collected 2 h later. Protein synthesis was increased by muscle contraction in CON mice. Sepsis suppressed the rate of synthesis in both the nonstimulated (31%) and stimulated (57%) muscle versus CON. Contraction of muscle in CON mice increased the phosphorylation of mTORC1 (mammalian target of rapamycin [mTOR] complex 1) substrates S6K1 (70-kd ribosomal protein S6 kinase 1) Thr (8-fold), S6K1 ThrSer (7-fold) and 4E-BP1 Ser (11-fold). Sepsis blunted the contraction-induced phosphorylation of S6K1 Thr (67%), S6K1 ThrSer (46%), and 4E-BP1 Ser (85%). Conversely, sepsis did not appear to modulate protein elongation as eEF2 Thr phosphorylation was decreased similarly by muscle contraction in both groups. Mitogen-activated protein kinase signaling was discordant following contraction in septic muscle; phosphorylation of extracellular signal-regulated kinase ThrTyr and p38 ThrTyr was increased similarly in both CON and CLP mice, while sepsis prevented the contraction-induced phosphorylation of JNK ThrTyr and c-JUN Ser. The expression of interleukin 6 and tumor necrosis factor α (TNF-α) mRNA in muscle was increased by sepsis, and contraction increased TNF-α to a greater extent in muscle from septic than CON mice. Injection of the mTOR inhibitor Torin2 in separate mice confirmed that contraction-induced increases in S6K1 and 4E-BP1 were mTOR mediated. These findings demonstrate that resistance to contraction-induced anabolic signaling occurs during sepsis and is predominantly mTORC1-dependent.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25423127      PMCID: PMC4359659          DOI: 10.1097/SHK.0000000000000304

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  33 in total

1.  Acquired weakness, handgrip strength, and mortality in critically ill patients.

Authors:  Naeem A Ali; James M O'Brien; Stephen P Hoffmann; Gary Phillips; Allan Garland; James C W Finley; Khalid Almoosa; Rana Hejal; Karen M Wolf; Stanley Lemeshow; Alfred F Connors; Clay B Marsh
Journal:  Am J Respir Crit Care Med       Date:  2008-05-29       Impact factor: 21.405

2.  Induction of interleukin 6 by human and murine recombinant interleukin 1 in mice.

Authors:  C Libert; P Brouckaert; A Shaw; W Fiers
Journal:  Eur J Immunol       Date:  1990-03       Impact factor: 5.532

Review 3.  mTor signaling in skeletal muscle during sepsis and inflammation: where does it all go wrong?

Authors:  Robert A Frost; Charles H Lang
Journal:  Physiology (Bethesda)       Date:  2011-04

4.  Contraction-induced changes in TNFalpha and Akt-mediated signalling are associated with increased myofibrillar protein in rat skeletal muscle.

Authors:  Leonidas G Karagounis; Ben B Yaspelkis; Donald W Reeder; Graeme I Lancaster; John A Hawley; Vernon G Coffey
Journal:  Eur J Appl Physiol       Date:  2010-03-13       Impact factor: 3.078

5.  Regulation of elongation factor 2 kinase by p90(RSK1) and p70 S6 kinase.

Authors:  X Wang; W Li; M Williams; N Terada; D R Alessi; C G Proud
Journal:  EMBO J       Date:  2001-08-15       Impact factor: 11.598

6.  Innate immune response in Th1- and Th2-dominant mouse strains.

Authors:  Hiroyuki Watanabe; Kousuke Numata; Takaaki Ito; Katsumasa Takagi; Akihiro Matsukawa
Journal:  Shock       Date:  2004-11       Impact factor: 3.454

7.  Evidence that tumor necrosis factor participates in the regulation of muscle proteolysis during sepsis.

Authors:  O Zamir; P O Hasselgren; S L Kunkel; J Frederick; T Higashiguchi; J E Fischer
Journal:  Arch Surg       Date:  1992-02

Review 8.  Regulation of muscle protein synthesis during sepsis and inflammation.

Authors:  Charles H Lang; Robert A Frost; Thomas C Vary
Journal:  Am J Physiol Endocrinol Metab       Date:  2007-05-15       Impact factor: 4.310

9.  Infection of inbred BALB/c and C57BL/6 and outbred Institute of Cancer Research mice with the emerging H7N9 avian influenza virus.

Authors:  Zhaoqin Zhu; Yuqin Yang; Yanling Feng; Bisheng Shi; Lixiang Chen; Ye Zheng; Di Tian; Zhigang Song; Chunhua Xu; Boyin Qin; Xiaonan Zhang; Wencai Guan; Fang Liu; Tao Yang; Hua Yang; Dong Zeng; Wenjiang Zhou; Yunwen Hu; Xiaohui Zhou
Journal:  Emerg Microbes Infect       Date:  2013-08-07       Impact factor: 7.163

10.  Defective inflammatory response in interleukin 6-deficient mice.

Authors:  E Fattori; M Cappelletti; P Costa; C Sellitto; L Cantoni; M Carelli; R Faggioni; G Fantuzzi; P Ghezzi; V Poli
Journal:  J Exp Med       Date:  1994-10-01       Impact factor: 14.307

View more
  11 in total

1.  Disruption of REDD1 gene ameliorates sepsis-induced decrease in mTORC1 signaling but has divergent effects on proteolytic signaling in skeletal muscle.

Authors:  Jennifer L Steiner; Kristen T Crowell; Scot R Kimball; Charles H Lang
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-10-20       Impact factor: 4.310

2.  Inability to replete white adipose tissue during recovery phase of sepsis is associated with increased autophagy, apoptosis, and proteasome activity.

Authors:  Kristen T Crowell; David I Soybel; Charles H Lang
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-01-18       Impact factor: 3.619

Review 3.  Emerging role for regulated in development and DNA damage 1 (REDD1) in the regulation of skeletal muscle metabolism.

Authors:  Bradley S Gordon; Jennifer L Steiner; David L Williamson; Charles H Lang; Scot R Kimball
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-05-17       Impact factor: 4.310

4.  Use of Organ Dysfunction as a Primary Outcome Variable Following Cecal Ligation and Puncture: Recommendations for Future Studies.

Authors:  Mabel N Abraham; Alexander P Kelly; Ariel B Brandwein; Tiago D Fernandes; Daniel E Leisman; Matthew D Taylor; Mariana R Brewer; Christine A Capone; Clifford S Deutschman
Journal:  Shock       Date:  2020-08       Impact factor: 3.454

5.  Protein arginine methyltransferase 1 modulates innate immune responses through regulation of peroxisome proliferator-activated receptor γ-dependent macrophage differentiation.

Authors:  Irina Tikhanovich; Jie Zhao; Jody Olson; Abby Adams; Ryan Taylor; Brian Bridges; Laurie Marshall; Benjamin Roberts; Steven A Weinman
Journal:  J Biol Chem       Date:  2017-03-22       Impact factor: 5.157

6.  Activation of the Akt/mTOR signaling pathway: A potential response to long-term neuronal loss in the hippocampus after sepsis.

Authors:  Jia-Nan Guo; Lin-Yu Tian; Wen-Yu Liu; Jie Mu; Dong Zhou
Journal:  Neural Regen Res       Date:  2017-11       Impact factor: 5.135

7.  Skeletal muscle atrogene expression and insulin resistance in a rat model of polytrauma.

Authors:  Robert M Akscyn; John L Franklin; Tatyana A Gavrikova; Joseph L Messina
Journal:  Physiol Rep       Date:  2016-02

Review 8.  Linking Cancer Cachexia-Induced Anabolic Resistance to Skeletal Muscle Oxidative Metabolism.

Authors:  Justin P Hardee; Ryan N Montalvo; James A Carson
Journal:  Oxid Med Cell Longev       Date:  2017-12-11       Impact factor: 6.543

9.  Pulmonary inflammation-induced loss and subsequent recovery of skeletal muscle mass require functional poly-ubiquitin conjugation.

Authors:  Judith J M Ceelen; Annemie M W J Schols; Nathalie G M Thielen; Astrid Haegens; Douglas A Gray; Marco C J M Kelders; Chiel C de Theije; Ramon C J Langen
Journal:  Respir Res       Date:  2018-05-02

10.  The impact of hindlimb disuse on sepsis-induced myopathy in mice.

Authors:  Orlando Laitano; Jose Pindado; Isela Valera; Ray A Spradlin; Kevin O Murray; Katelyn R Villani; Jamal M Alzahrani; Terence E Ryan; Philip A Efron; Leonardo F Ferreira; Elisabeth R Barton; Thomas L Clanton
Journal:  Physiol Rep       Date:  2021-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.